|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 4/20/2022 2:08:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.J. Res. 75, Extension of Continuing Appropriations Act, 2022, provisions relating to 4-day CR
H.R. 2471, Consolidated Appropriations Act, 2022, provisions relating to full CR for FY2022, COVID-19 and telehealth
H.R. 4521, America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (America COMPETES) Act of 2022, provisions relating to Section 80303 and Doctoral STEM Programs
H.R. 5376, Build Back Better Act, provisions relating to Pathways to Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 924, Rural America Health Corps Act, all provision
H.R. 5602, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions
S. 3244, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions
H.R. 4122, Resident Education Deferred Interest (REDI) Act, all provisions
S. 3658, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 2917, Retirement Parity for Student Loans Act of 2021, all provisions
S. 1443, Retirement Parity for Student Loans Act of 2021, all provisions
H.R. 2954, Securing a Strong Retirement Act of 2022, provisions relating to student loans
H.R. 944, To amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians, and for other purposes, all provisions
H. Res. 784, Expressing the sense of the House of Representatives that the United States recognizes the mounting personal and financial burden of diet-related disease in the United States and calls on medical schools, graduate medical education programs, and other health professional training programs to provide meaningful physician and health professional education on nutrition and diet, all provisions
H.R. 6397, Medical Student Education Authorization Act of 2022, all provisions
S. 3497, Medical Student Education Authorization Act of 2022, all provisions
Foreign Medical School Accountability Act/draft
Student loan forgiveness for frontline workers
Osteopathic residency/discrimination issues
United States Medical Licensing Examination
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions
S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions
H.R. 1218, Data Mapping to Save Moms Lives Act, all provisions
S. 198, Data Mapping to Save Moms' Lives Act, all provisions
H.R. 4387, Maternal Health Quality Improvement Act of 2021, all provisions
S. 1675, Maternal Health Quality Improvement Act, all provisions
H.R. 1446, Enhanced Background Checks Act of 2021, all provisions
H.R. 8, Bipartisan Background Checks Act of 2021, all provisions
H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions
S. 610, Dr. Lorna Breen Health Care Provider Protection Act, all provisions
H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions
S. 104, Improving Social Determinants of Health Act of 2021, all provisions
S. 54, Strengthening Americas Health Care Readiness Act, all provisions
H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions
H.R. 3753, Parity Implementation Assistance Act, all provisions
S. 1962, Parity Implementation Assistance Act, all provisions
S. 3904, Healthcare Cybersecurity Act of 2022, all provisions
H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions
S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions
H.R. 6000, Cures 2.0 Act, all provisions
S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, all provisions
S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions
S. 2866, Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act, all provisions
H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to waste, fraud, and abuse in telehealth
S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to waste, fraud, and abuse and telehealth
H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions
H.R. 1306, National Coronavirus Commission Act of 2021, all provisions
S. 412, National Coronavirus Commission Act of 2021, all provisions
H.R. 1843, COVID-19 Hate Crimes Act, all provisions
S.937, COVID-19 Hate Crimes Act, all provisions
H.R. 6279, Opioid Treatment Access Act of 2022, all provisions
H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions
S. 1976, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions
H.R. 6904, Patients Before Profits Act of 2022, all provisions
H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions
S. 3039, Social Determinants Accelerator Act of 2021, all provisions
H.R. 6072, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions
S. 509, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions
H.R. 5224, Preventing Overdoses and Saving Lives Act of 2021, all provisions
H.R. 925, Data to Save Moms Act, all provisions
H.R. 3352, Midwives for MOMS Act of 2021, all provisions
H.R. 847, Promoting Digital Privacy Technologies Act, all provisions
S. 224, Promoting Digital Privacy Technologies Act, all provisions
H.R. 4098, Non-Opioid Directive Act, all provisions
S. 3620, Health Data Use and Privacy Commission Act, all provisions
Emergency Room Hero and Patient Safety Act
Primary Care Physician Reentry Act
21st Century Cures Act/implementation
Affordable Care Act (ACA)/Stabilization
Ryan Haight Act/telemedicine/controlled substances
No Surprises Act/implementation
Physician workforce issues
Opioid overdose epidemic
Medical device user fee reauthorization
Telehealth study
COVID-19/vaccine distribution/vaccine in physician offices
COVID-19/health equity/vaccine
COVID-19/testing/personal protective equipment(PPE)/misinformation
Pandemic preparedness and public health
Health insurance affordability
Mental health parity
Prior authorization
Health equity and technology/biometric technologies
Health Equity
COVID-19/Provider Relief Fund
Modifier 25/OIG
Information blocking/Patient privacy
Naloxone/over the counter (OTC)
EHR Certification
Precision medicine/diagnostics/coverage/payment/coding
Digital health/AI/Digital therapeutics/transparency/equity
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), White House Office, Centers For Disease Control & Prevention (CDC), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Danielle |
Turnipseed |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Bryan |
Hull |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 3541, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 1810, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 6, American Dream and Promise Act of 2021, all provisions
H.R. 2255, Healthcare Workforce Resilience Act, all provisions
S. 1024, Healthcare Workforce Resilience Act, all provisions
H.R. 6617, Further Additional Extending Government Funding Act, provisions relating to Conrad 30
H.R. 2471, Consolidated Appropriations Act, 2022, provisions relating to immigration
Immigration
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in health insurance
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes, all provisions
H.R. 315, Medicare Sequester COVID Moratorium Act, all provisions
H.R. 6020, Supporting Medicare Providers Act of 2021, all provisions
S. 3314, Supporting Medicare Providers Act of 2021, all provisions
S. 610, Protecting Medicare and American Farmers from Sequester Cuts Act, all provisions
H.R. 6048, Medicare Stability for Patients and Providers Act, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions
H.R. 19, Lower Costs, More Cures Act of 2021, all provisions
H.R. 3259, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, all provisions
S. 586, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, all provisions
H.R. 3441, Substance Use Disorder Workforce Act, all provisions
S. 1438, Opioid Workforce Act of 2021, all provisions
H.R. 1332, Telehealth Modernization Act, all provisions
S. 368, Telehealth Modernization Act, all provisions
H.R. 2903, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021, all provisions
S. 1512, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021, all provisions
H.R. 4058, Telemental Health Care Access Act of 2021, all provisions
S. 2061, Telemental Health Care Access Act of 2021, all provisions
S. 801, Connected Maternal Online Monitoring Act, all provisions
S. 346, Black Maternal Health Momnibus Act of 2021, all provisions
H.R. 3407, Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act, all provisions
S. 411, Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act, all provisions
H.R. 1738, Stabilize Medicaid and CHIP Coverage Act, all provisions
H.R. 1025, Kids Access to Primary Care Act of 2021, all provisions
H.R. 66, Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids Act, all provisions
H.R. 2256, Resident Physician Shortage Reduction Act of 2021, all provisions
S. 834, Resident Physician Shortage Reduction Act of 2021, all provisions
H.R. 3173, Improving Seniors Timely Access to Care Act of 2021, all provisions
S. 3018, Improving Seniors Timely Access to Care Act of 2021, all provisions
S. 748, Medicare Sequester Relief Act, all provisions
H.R. 2163, Safe Step Act, all provisions
S. 464, Safe Step Act, all provisions
H.R. 955, Medicaid Reentry Act of 2021, all provisions
S. 285, Medicaid Reentry Act of 2021, all provisions
H.R. 2654, Chiropractic Medicare Coverage Modernization Act of 2021, all provisions
H.R. 4587, Value in Health Care Act of 2021, all provisions
H.R. 6000, Cures 2.0 Act, all provisions
H.R. 4043, Ensuring Patient Access to Critical Breakthrough Products Act of 2021, all provisions
S. 2416, New Opportunities for Value that Extend Lives (NOVEL) Act of 2021, all provisions
H.R. 6311, Comprehensive Addiction Resources Emergency (CARE) Act of 2021, all provisions
S. 3418, Comprehensive Addiction Resources Emergency (CARE) Act of 2021, all provisions
H.R. 4014, Physician Shortage GME Cap Flex Act of 2021, all provisions
S. 2094, Physician Shortage GME Cap Flex Act of 2021, all provisions
H.R. 6202, Telehealth Extension Act of 2021, all provisions
S. 3593, Telehealth Extension and Evaluation Act, all provisions
H.R. 2807, Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies (PREVENT DIABETES) Act, all provisions
S. 2173, Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies (PREVENT DIABETES) Act, all provisions
H.R. 5804, Expanding Access to Diabetes Self-Management Training Act of 2021, all provisions
S. 2203, Expanding Access to Diabetes Self-Management Training Act of 2021, all provisions
S. 596, Treat and Reduce Obesity Act of 2021, all provisions
H.R. 2166, Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021, all provisions
H.R. 366, Protecting Access to Post-COVID-19 Telehealth Act of 2021, all provisions
H.R. 2228, Rural Behavioral Health Access Act of 2021, all provisions
H.R. 3447, Permanency for Audio-Only Telehealth Act, all provisions
H.R. 7051, Access to Prescription Digital Therapeutics Act of 2022, all provisions
S. 3791, Access to Prescription Digital Therapeutics Act of 2022, all provisions
H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions
S. 3039, Social Determinants Accelerator Act of 2021, all provisions
H.R. 987, CARA 3.0 Act of 2021, all provisions
H.R. 925, Data to Save Moms Act, all provisions
H.R. 3746, Accountable Care in Rural America Act, all provisions
H.R. 4755, Seniors Chronic Care Management Improvement Act of 2021, all provisions
H.R. 6308, ACO Assignment Improvement Act of 2021, all provisions
H.R. 6583, Stop the Wait Act of 2022, all provisions
S. 224, Stop the Wait Act of 2022, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions
H.R. 7213, Equitable Community Access to Pharmacist Services Act, all provisions
Medicare program: Gold Card Act/draft
Medicare program: 21st Century Cures Act
Medicare program: Protecting Access to Medicare Act (PAMA)/Laboratory testing/diagnostics
Medicare program: Small Practice, Underserved, and Rural Support Program (SURS) Extension Act of 2022
Medicare program: Telehealth and dialysis centers/COVID-19 flexibilities continuation
Medicare program: Telehealth/telephone visit codes/equity/quality
Medicare program: Physician Payment Reform
Medicare program: MEDPAC Report
Medicare program: 2% Medicare sequester moratorium/continuation
Medicare program: 4% Medicare sequester/Statutory PAYGO
Medicare program: Physician payment/inflation index
Medicare program: Medicare Physician Fee Schedule Conversion Factor/extension of 3% increase
Medicare program: Medicare Diabetes Prevention Program (MDPP) model
Medicare program: Global and Professional Direct Contracting Model (GPDC)/Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH)
Medicare program: Evaluation and Management (E/M)/budget neutrality
Medicare program: Prior authorization
Medicare program: Interoperability
Medicare program: EFT fees
Medicare program: Merit-based Incentive Payment System (MIPS)/Quality/Cost/Improvement activities
Medicare program: MIPS Value Pathways (MVPs)
Medicare program: MIPS draft cost measures/field testing extension
Medicare program: Value-based care acceleration/transparency/stability
Medicare program: Virtual credit cards
Medicare program: Primary Care First models
Medicare program: Medicare Shared Savings Program (MSSP)
Medicare program: RVS Update Committee (RUC)/Current Procedural Terminology (CPT)
Medicare program: Split/shared billing
Medicare program: PECOS Enrollment/Revalidation
Medicare program: Open Payments
Medicare program: Step Therapy
Medicare program: Public health emergency/accelerated and advance payments
Medicare program: MACRA oversight
Medicare program: MACRA/physician burdens
Medicare program: Alternative payment models (APMs)
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/implementation/Accountable Care Organizations
Medicare and Medicaid programs: Information blocking/Patient privacy
Medicare and Medicaid programs: COVID-19 response
Medicare and Medicaid programs: Mental Health Parity and Addiction Equity Act (MHPAEA)/patient protection
Medicare and Medicaid programs: Health equity/COVID-19
Medicare and Medicaid programs: Drug overdose epidemic
Medicare and Medicaid programs: Health IT burdens
Medicaid program: Medicaid funding in US territories
Medicaid program: Uninsured individuals/COVID-19
Medicaid program: Special enrollment period
Medicaid program: Sickle Cell Disease
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
Danielle |
Turnipseed |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Bryan |
Hull |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 2079, Eliminating the Provider Relief Fund Tax Penalties Act of 2021, all provisions
Primary and Virtual Care Affordability Act/draft
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 3021, Coronavirus Provider Protection Act, all provisions
Public Readiness and Emergency Preparedness (PREP) Act/provider liability protections
Medical Liability Insurance/premium increases
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 958, Protecting Moms Who Served Act, all provisions
S. 796, Protecting Moms Who Served Act of 2021, all provisions
H.R. 7048, Protect Lifesaving Anesthesia Care for Veterans Act of 2022, all provisions
S. 2041, Department of Veterans Affairs Provider Accountability Act, all provisions
Primary Care Physician Reentry Act
VA Supremacy Project/Scope
Veterans Choice/Community Care Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Chase |
Thomas |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |